Case number 2016-1109
Millennium Pharmaceuticals v. Apotex Corp. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 27, 2017 | 22 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [471000] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762] [SJ] [Entered: 10/27/2017 09:40 AM] (2) |
| Jul 17, 2017 | 21 | OPINION and JUDGMENT filed. The judgment or decision is: Reversed-in-part and Remanded-in-part in 15-2066, 16-1008, 16-1009, 16-1010, 16-1110, 16-1283, 16-1762; Vacated-in-part and Remanded-in-part in 16-1109. (Precedential Opinion). (For the Court: Newman,Circuit Judge; Mayer,Circuit Judge and O'Malley,Circuit Judge). [446874] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762] [JAB] [Entered: 07/17/2017 10:14 AM] (25) |
| Nov 6, 2015 | 18 | NOTICE OF DEFICIENCY: The certificate of interest Document No. [16], attorney entries of appearance Document No. [15], [11], [12], [13], and [14] filed by Appellee Teva Pharmaceuticals USA, Inc. are without a proper/complete proof of service and therefore cannot be accepted for filing at this time. Additionally, in cases consolidated by the court, documents should be filed in the lead appeal only. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice and filed in the lead appeal 15-2066. [286821] --[Edited 11/06/2015 by clerk to correct docket text] [JB] [Entered: 11/06/2015 09:13 AM] (0) |
| Nov 6, 2015 | 19 | NOTICE OF DEFICIENCY: The docketing statement Document No. [17] filed by Appellee Teva Pharmaceuticals USA, Inc. in 16-1109 is not submitted in the lead appeal and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice and filed in the lead appeal 15-2066. [286832] [IW] [Entered: 11/06/2015 09:27 AM] (0) |
| Nov 6, 2015 | 20 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [15] filed by Appellee Teva Pharmaceuticals USA, Inc. in 16-1109 , attorney entry of appearance Document No. [14] filed by Appellee Teva Pharmaceuticals USA, Inc. in 16-1109 , attorney entry of appearance Document No. [13] filed by Appellee Teva Pharmaceuticals USA, Inc. in 16-1109 , attorney entry of appearance Document No. [12] filed by Appellee Teva Pharmaceuticals USA, Inc. in 16-1109 , attorney entry of appearance Document No. [11] filed by Appellee Teva Pharmaceuticals USA, Inc. in 16-1109 , certificate of interest Document No. [16] filed by Appellee Teva Pharmaceuticals USA, Inc. in 16-1109 is without a proper/complete proof of service and therefore cannot be accepted for filing at this time. Also, these documents were filed under the lead appeal case number, however the face of the documents still list 16-1109 as the case number for these filings. Please conform the documents to reflect the lead appeal number of 15-2066. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [286840] [JCA] [Entered: 11/06/2015 09:35 AM] (0) |
| Nov 5, 2015 | 11 | Entry of appearance for Mark D. Schuman as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286727] [Mark Schuman] [Entered: 11/05/2015 05:08 PM] (0) |
| Nov 5, 2015 | 12 | Entry of appearance for Todd S. Werner as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286730] [Todd Werner] [Entered: 11/05/2015 05:10 PM] (0) |
| Nov 5, 2015 | 13 | Entry of appearance for Samuel T. Lockner as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286731] [Samuel Lockner] [Entered: 11/05/2015 05:11 PM] (0) |
| Nov 5, 2015 | 14 | Entry of appearance for Jennell C. Bilek as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286733] [Jennell Bilek] [Entered: 11/05/2015 05:16 PM] (0) |
| Nov 5, 2015 | 15 | Entry of appearance for Alexandra J. Olson as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286734] [Alexandra Olson] [Entered: 11/05/2015 05:18 PM] (0) |
| Nov 5, 2015 | 16 | Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286735] [Mark Schuman] [Entered: 11/05/2015 05:19 PM] (0) |
| Nov 5, 2015 | 17 | Docketing Statement for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/05/2015 by email. [286743] [Mark Schuman] [Entered: 11/05/2015 05:26 PM] (0) |
| Nov 2, 2015 | 9 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [8] filed by Appellees Apotex Inc. and Apotex Corp. in 16-1109 , docketing statement Document No. [7] filed by Appellees Apotex Inc. and Apotex Corp. in 16-1109 , certificate of interest Document No. [6] filed by Appellees Apotex Inc. and Apotex Corp. in 16-1109 , attorney entry of appearance Document No. [5] filed by Appellees Apotex Inc. and Apotex Corp. in 16-1109 is not submitted in the lead appeal and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected documents may be accepted for filing if received before midnight (EST) on the date of this notice. [285044] [JAB] [Entered: 11/02/2015 07:47 AM] (0) |
| Nov 2, 2015 | 10 | CORRECTED ORDER: correcting clerk order to consolidate appeals [2], clerk order [2]; reason(s): to correct appellant's opening brief deadline. Service as of this date by Clerk of Court. [285098] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110] [CAB] [Entered: 11/02/2015 09:52 AM] (2) |
| Oct 30, 2015 | 2 | ORDER consolidating appeals (15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110). Service as of this date by Clerk of Court. [284905] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110] [CAB] [Entered: 10/30/2015 02:55 PM] (0) |
| Oct 30, 2015 | 3 | Note to file: The following cases are associated:15-2066 (Lead) with 16-1008, -1009, -1010, -1109, and -1110 (Consolidated). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [284931] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110] [CAB] [Entered: 10/30/2015 03:33 PM] (0) |
| Oct 30, 2015 | 4 | Entry of appearance for William A. Rakoczy as principal counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 10/30/2015 by email. [285030] [William Rakoczy] [Entered: 10/30/2015 08:21 PM] (1) |
| Oct 30, 2015 | 5 | Corrected Entry of appearance for William A. Rakoczy as principal counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 10/30/2015 by email. [285032] [William Rakoczy] [Entered: 10/30/2015 08:46 PM] (0) |
| Oct 30, 2015 | 6 | Certificate of Interest for the Appellees Apotex Corp. and Apotex Inc.. Service: 10/30/2015 by email. [285033] [William Rakoczy] [Entered: 10/30/2015 08:50 PM] (0) |
| Oct 30, 2015 | 7 | Docketing Statement for the Appellees Apotex Corp. and Apotex Inc.. Service: 10/30/2015 by email. [285034] [William Rakoczy] [Entered: 10/30/2015 08:52 PM] (0) |
| Oct 30, 2015 | 8 | Entry of appearance for Peter J. Curtin as of counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 10/30/2015 by email. [285035] [William Rakoczy] [Entered: 10/30/2015 09:00 PM] (0) |
| Oct 22, 2015 | 1 | Appeal docketed. Received: 10/20/2015. [282831]Entry of Appearance due 11/05/2015. Certificate of Interest is due on 11/05/2015. Docketing Statement due 11/05/2015. Appellant/Petitioner's brief is due 12/21/2015. [JW] [Entered: 10/22/2015 03:33 PM] (16) |
